New York, Jan 18, 2026, 17:31 EST — Market closed.
Intuitive Surgical Inc (ISRG.O) last closed down 1.2% at $535 on Friday, Jan. 16. U.S. equity markets are closed on Monday, Jan. 19, for the Martin Luther King Jr. Day holiday, with trading set to resume Tuesday. (NASDAQ Trader)
That gives investors a little more time to chew on Intuitive’s fresh outlook for da Vinci procedure growth in 2026 ahead of the company’s next results. The stock has been moving on small shifts in that outlook, and this one landed awkwardly.
Procedure growth is the rise in the number of surgeries done with Intuitive’s da Vinci robots, and it drives recurring sales of instruments and accessories used in each case.
The company said preliminary fourth-quarter revenue was about $2.87 billion, up 19% from a year earlier, and 2025 revenue about $10.06 billion, up 21%. Instruments and accessories revenue (tools used in each operation) was about $1.66 billion for the quarter, up 17%, while worldwide da Vinci procedures rose about 17%, it said. Intuitive expects da Vinci procedure growth of about 13% to 15% in 2026 and placed 532 da Vinci systems in the quarter, including 303 da Vinci 5 systems. (Nasdaq)
Chief Executive Dave Rosa said the company saw “more than 3.1 million da Vinci procedures performed” in 2025. Intuitive, based in Sunnyvale, California, also sells the Ion endoluminal system. The company said its figures are unaudited preliminary results and could still change as it completes its year-end close and audit. (GlobeNewswire)
Bloomberg said the 13%-15% procedure-growth range sits below a 15.2% analyst consensus and would mark the slowest pace since 2020. For a stock priced on steady procedure gains, even a small trim to that line can hit the shares. (Bloomberg)
Evercore ISI analyst Vijay Kumar wrote that the sales beat was driven largely by system revenue, with a greater share sold upfront rather than through leases. “The systems rev beat partly reflects higher average selling prices,” he said, keeping an in-line rating and a $580 price target. (Investors)
Medical-device peers were mixed on Friday. Medtronic fell 2.26% and Stryker rose 0.36%, while the S&P 500 dipped, MarketWatch data showed. (MarketWatch)
But the next update can still disappoint if procedure growth cools faster than expected, especially if hospitals slow big capital purchases. The company’s quarterly numbers can also swing on the mix of system sales versus leases, which affects near-term revenue timing.
Traders get their first chance to reset ISRG on Tuesday, then the focus shifts to Intuitive’s Jan. 22 results and any changes to its 2026 procedure outlook. Rate-sensitive names also have the Federal Reserve’s Jan. 27–28 meeting on the calendar later this month. (Nasdaq)
